How AI-Driven Cell Therapy is Rewriting Regeneration with Frank Li

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/80/10/b3/8010b3ad-72f4-0767-ddc4-5d73e38b2d11/mza_2038256993057657026.jpg/600x600bb.jpg

The Bits in Bio Podcast

Robbie Matthews and Vincent Alessi

4 episodes

2 weeks ago

Hosts Robbie and Vince explore techbio’s hidden machinery—venture hype, lab experiments, and algorithmic dreams—to reveal what works, what spectacularly fails, and the stubborn realities of turning code into biology.

Technology

RSS

All content for The Bits in Bio Podcast is the property of Robbie Matthews and Vincent Alessi and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Technology

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/44223163/44223163-1754975923752-7bcd94853aa1.jpg

How AI-Driven Cell Therapy is Rewriting Regeneration with Frank Li

The Bits in Bio Podcast

36 minutes 50 seconds

1 month ago

How AI-Driven Cell Therapy is Rewriting Regeneration with Frank Li

Frank Li, founder and CEO of Stately Bio, joins us to unpack how AI-driven, label-free live-cell imaging is unlocking real-time insight into cell state and redefining what’s possible in regenerative medicine.

We discuss his journey from co-founding a mobile payments startup through roles at Palantir, Google Brain, and Calico, to building Stately Bio’s ML imaging platform, and how surprising predictive power emerges when you stream and analyze living cells at scale.

From three years in stealth to a $12M seed round, Frank shares lessons on bridging tech and biotech, building a world-class technical team, and applying AI to one of biology’s most complex frontiers.